Heritage Wealth Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-38
Closed -$18.9K – 602
2026
Q2
$18.9K Hold
38
– – ﹤0.01% 448
2026
Q1
$17K Buy
38
+35
+1,167% +$16.3K ﹤0.01% 459
2025
Q4
$1.36K Hold
3
– – ﹤0.01% 551
2025
Q3
$1.18K Sell
3
-50
-94% -$20.9K ﹤0.01% 540
2025
Q2
$23.6K Hold
53
– – ﹤0.01% 357
2025
Q1
$25.7K Buy
53
+23
+77% +$10.7K ﹤0.01% 349
2024
Q4
$12.1K Buy
30
+23
+329% +$10.7K ﹤0.01% 429
2024
Q3
$3.26K Buy
+7
New +$3.36K ﹤0.01% 519
2020
Q1
– Sell
-7
Closed -$1.53K – 586
2019
Q4
$1.53K Buy
+7
New +$1.42K ﹤0.01% 607

Other funds holding VRTX

Heritage Wealth Advisors's VRTX Position: Q3 2026 in Review

Heritage Wealth Advisors sold out of Vertex Pharmaceuticals (VRTX) in Q3 2026, closing a stake of 38 shares — an estimated $18.9K sold.

Heritage Wealth Advisors first reported a position in VRTX in Q4 2019 and held it in 9 quarters. The position peaked at $25.7K in Q1 2025. 1,786 funds tracked by Wall St. Rank hold VRTX as of Q3 2026.

  • Heritage Wealth Advisors reported no remaining Vertex Pharmaceuticals position as of Q3 2026 after selling out during the quarter.
  • Heritage Wealth Advisors sold 38 Vertex Pharmaceuticals shares in Q3 2026, an estimated $18.9K.
  • Heritage Wealth Advisors first reported a position in Vertex Pharmaceuticals in Q4 2019 and held it in 9 quarters.
  • Heritage Wealth Advisors's Vertex Pharmaceuticals position peaked at $25.7K in Q1 2025.
  • 1,786 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2026.

Based on Heritage Wealth Advisors's 13F filing for Q3 2026, filed 9 Nov 2026.